Since indomethacin and potassium-sparing diuretics, including MIDAMOR, may each be associated with increased serum potassium levels, the potential effects on potassium kinetics and renal function should be considered when these agents are administered concurrently.
<indomethacin, effect, potassium-sparing diuretics>, <indomethacin, effect, MIDAMOR>